Biogen has agreed to acquire Apellis Pharmaceuticals for about $5.6 billion in cash, expanding its portfolio of rare-disease medicines.
Source: US Top News and Analysis
Related Posts
I’ve studied over 200 kids. Here’s the No. 1 skill parents are forgetting to teach kids today
Parents today try to raise their children for good grades and high achievement. But that’s…
Asia-Pacific markets set to fall as Middle East war enters fifth week
Asia-Pacific markets are set to fall Monday as the Middle East war enters its fifth…
‘No Kings’ protest rallies against Trump planned in thousands of U.S. cities
A nationwide wave of protests is set to sweep across the United States, with thousands…